PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PetMed Express, Inc.

In a report released yesterday, Manjari Dhar from RBC Capital maintained a Sell rating on Pets at Home, with a price target of p180.00. According t...

RBC Capital Reaffirms Their Sell Rating on Pets at Home (PETS)

The latest update is out from Petmed Express ( ($PETS) ). On July 23, 2026, PetMed Express’ real estate subsidiary agreed to sell its headquarters ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PETS	$1.87	-7.93%	112.43K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PETS	$1.87	-7.9%	112.43K
3
4
5
6

PETS

Get PetMed Express, Inc. Data in Excel

Get PetMed Express, Inc. Data in Excel